First Topical Therapy for Chronic Hand Eczema Wins FDA Approval

(MedPage Today) — The first therapy specifically indicated for chronic hand eczema (CHE) has passed muster at the FDA.
The agency approved delgocitinib cream 2% (Anzupgo) for adults with moderate-to-severe CHE, according to a statement from LEO…

Source link : https://www.medpagetoday.com/dermatology/atopy/116653

Author :

Publish date : 2025-07-24 14:45:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
	1	2	3	4	5	6
7	8	9	10	11	12	13
14	15	16	17	18	19	20
21	22	23	24	25	26	27
28	29	30	31

First Topical Therapy for Chronic Hand Eczema Wins FDA Approval

The Fertility Rate Reached a New Low in 2024, CDC Data Show

Thousands of seadragons are dying in Australia’s toxic algal bloom

Related Posts

Study Touts Benefit of Mini Nonhormonal IUD — But It’s Not Sold in the U.S.

Could Direct Primary Care’s Popularity Be on the Rise?

Will ‘Safe Staffing Committee’ Laws Help Reduce ED Wait Times?

Ultraprocessed Foods Tied to Worse Parkinson’s Outcomes

Undetected Eye Disease May Be Common in Black Adults

Neanderthals were probably maggot-munchers, not hyper-carnivores

Study Touts Benefit of Mini Nonhormonal IUD — But It’s Not Sold in the U.S.

Could Direct Primary Care’s Popularity Be on the Rise?

Will ‘Safe Staffing Committee’ Laws Help Reduce ED Wait Times?

Ultraprocessed Foods Tied to Worse Parkinson’s Outcomes

Undetected Eye Disease May Be Common in Black Adults

Neanderthals were probably maggot-munchers, not hyper-carnivores

More Drug Coverage Denials; New 5-Year Survival in Liver Cancer; Dx in a NUTshell

Study Suggests COVID Shots Saved Fewer Lives Compared With Prior Estimates

Categories

Archives